Related Experiment Videos

Increased serum osteoprotegerin level in older and diabetic hemodialysis patients

Shigehiro Doi1, Noriaki Yorioka, Takao Masaki

  • 1Harada Hospital, Department of Blood Purification, Graduate School of Biochemical Sciences, Hiroshima University, Hiroshima City, Japan.

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|July 28, 2004
PubMed

Insights

Serum osteoprotegerin levels are elevated in hemodialysis patients, increasing with age, dialysis duration, and diabetes. This may explain adynamic bone disease prevalence in these patient groups.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Osteoprotegerin (OPG) is a key inhibitor of osteoclastogenesis.
  • Elevated serum OPG levels are observed in patients undergoing hemodialysis.
  • The relationship between OPG and clinical parameters in hemodialysis patients requires further investigation.

Purpose of the Study:

  • To investigate the correlation between serum osteoprotegerin levels and clinical parameters in hemodialysis patients.
  • To explore potential links between OPG, aging, dialysis duration, diabetes, and bone disease.

Main Methods:

  • Serum OPG levels were measured using enzyme-linked immunosorbent assay (ELISA).
  • Stepwise multiple regression analysis was employed to analyze data.
  • Study included 82 hemodialysis patients (45 men, 37 women; age 27-94 years).

Main Results:

  • Hemodialysis patients exhibited higher mean OPG levels (303 +/- 210 pg/mL) compared to age-matched controls.
  • Serum OPG levels positively correlated with patient age, duration of dialysis, and presence of diabetes.
  • These factors may contribute to increased skeletal resistance to parathyroid hormone.

Conclusions:

  • Elevated serum osteoprotegerin in hemodialysis patients is associated with age, dialysis duration, and diabetes.
  • These associations may contribute to the higher incidence of adynamic bone disease in older and diabetic hemodialysis patients.
  • Further research is warranted to elucidate the precise mechanisms linking OPG to bone metabolism disturbances in this population.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...